PRVA Strangle Strategy
PRVA (Privia Health Group, Inc.), in the Healthcare sector, (Medical - Healthcare Information Services industry), listed on NASDAQ.
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
PRVA (Privia Health Group, Inc.) trades in the Healthcare sector, specifically Medical - Healthcare Information Services, with a market capitalization of approximately $2.85B, a trailing P/E of 129.10, a beta of 0.97 versus the broader market, a 52-week range of 18.77-26.51, average daily share volume of 949K, a public-listing history dating back to 2021, approximately 1K full-time employees. These structural characteristics shape how PRVA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.97 places PRVA roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 129.10 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a strangle on PRVA?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current PRVA snapshot
As of May 15, 2026, spot at $22.98, ATM IV 19.40%, IV rank 5.62%, expected move 5.56%. The strangle on PRVA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on PRVA specifically: PRVA IV at 19.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a PRVA strangle, with a market-implied 1-standard-deviation move of approximately 5.56% (roughly $1.28 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PRVA expiries trade a higher absolute premium for lower per-day decay. Position sizing on PRVA should anchor to the underlying notional of $22.98 per share and to the trader's directional view on PRVA stock.
PRVA strangle setup
The PRVA strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PRVA near $22.98, the first option leg uses a $24.13 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PRVA chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PRVA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $24.13 | N/A |
| Buy 1 | Put | $21.83 | N/A |
PRVA strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
PRVA strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on PRVA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on PRVA
Strangles on PRVA are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PRVA chain.
PRVA thesis for this strangle
The market-implied 1-standard-deviation range for PRVA extends from approximately $21.70 on the downside to $24.26 on the upside. A PRVA long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current PRVA IV rank near 5.62% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PRVA at 19.40%. As a Healthcare name, PRVA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PRVA-specific events.
PRVA strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PRVA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PRVA alongside the broader basket even when PRVA-specific fundamentals are unchanged. Always rebuild the position from current PRVA chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on PRVA?
- A strangle on PRVA is the strangle strategy applied to PRVA (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With PRVA stock trading near $22.98, the strikes shown on this page are snapped to the nearest listed PRVA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PRVA strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the PRVA strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 19.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PRVA strangle?
- The breakeven for the PRVA strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PRVA market-implied 1-standard-deviation expected move is approximately 5.56%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on PRVA?
- Strangles on PRVA are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PRVA chain.
- How does current PRVA implied volatility affect this strangle?
- PRVA ATM IV is at 19.40% with IV rank near 5.62%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.